A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression.
Nagele P, Palanca BJ, Gott B, Brown F, Barnes L, Nguyen T, Xiong W, Salloum NC, Espejo GD, Lessov-Schlaggar CN, Jain N, Cheng WWL, Komen H, Yee B, Bolzenius JD, Janski A, Gibbons R, Zorumski CF, Conway CR.
Nagele P, et al.
Sci Transl Med. 2021 Jun 9;13(597):eabe1376. doi: 10.1126/scitranslmed.abe1376.
Sci Transl Med. 2021.
PMID: 34108247
Clinical Trial.